Ironwood Insider Moves: Director Denner Buys 16.4 Million Shares, Officer Ronald Sells 35,000 Amid Bullish Outlook
Insider buying dominates Ironwood: Ronald’s modest sell under a Rule 10b‑5 plan contrasts with Director Denner’s aggressive accumulation, signaling bullish confidence amid strong earnings and a $4.30 price well below year highs.
- Ironwood Pharmaceuticals Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read